Yahoo Web Search

Search results

1. People also ask

   Who is Mark Goldberg?

   • Join us in supporting multicultural communities. Mark Goldberg, MD, is a medical oncologist and hematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time American Cancer Society and American Cancer Society Cancer Action Network volunteer. Dr.

   Mark Goldberg Bio - American Cancer Society

   www.cancer.org/about-us/financial-governance-information/board-of-directors/mark-goldberg-bio.html

   See all results for this question

   Who is Dr Goldberg on the Board of directors?

   • Dr. Goldberg currently serves on the boards of directors of ImmunoGen, GlycoMimetics, Walden Biosciences, Avacta Group plc, and Blueprint Medicines. Dr.

   Mark Goldberg Bio - American Cancer Society

   www.cancer.org/about-us/financial-governance-information/board-of-directors/mark-goldberg-bio.html

   See all results for this question

   Who is Mark Sullivan?

   • Mark Sullivan was well on his way to rising through the ranks of the traditional pharma world. Instead, he went another way, launching a nonprofit pharma company in 2005 to develop drugs that address health inequity in marginalized and isolated communities — particularly drugs that focus on neglected tropical diseases.

   The 2022 PharmaVoice 100 | PharmaVoice

   www.pharmavoice.com/news/pv100-pharma-industry-leaders-next-era/629818/

   See all results for this question

2. www.pharmavoice.com › news › red-jacket-dr-markRed Jacket: Dr. Mark Goldberg, a clinical innovator

   www.pharmavoice.com › news › red-jacket-dr-mark

   • Cached

   Oct 27, 2023 · Dr. Mark Goldberg. CEO and chairman, Allucent. Since its founding in 2018, Allucent has run about 1,000 clinical trials in roughly 70 countries and played a hand in more than 50 marketing authorizations in either the U.S. or Europe.

   • Legacy Leaders: Dr. Mark Goldberg

     Three years ago, Dr. Mark Goldberg embarked on a bold vision...

3. www.cancer.org › mark-goldberg-bioMark Goldberg | American Cancer Society | Board of Directors

   www.cancer.org › mark-goldberg-bio

   • Cached

   Mark Goldberg, MD, is a medical oncologist and hematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time American Cancer Society and American Cancer Society Cancer Action Network volunteer.

4. www.pharmavoice.com › news › mark-a-goldberg-pv100Legacy Leaders: Dr. Mark Goldberg - PharmaVoice

   www.pharmavoice.com › news › mark-a-goldberg-pv100

   • Cached

   Sep 6, 2022 · Three years ago, Dr. Mark Goldberg embarked on a bold vision to create a world-class CRO addressing the clinical trial challenges and needs of small to midsized biopharma companies. To achieve his goal, Goldberg is leaning into his more than 20 years of experience at Parexel, a global clinical research organization where he spent the past ...

5. www.linkedin.com › in › mark-goldberg-29a67630Mark Goldberg - American Cancer Society | LinkedIn

   www.linkedin.com › in › mark-goldberg-29a67630

   View Mark Goldberg’s profile on LinkedIn, a professional community of 1 billion members. Experience: American Cancer Society · Education: Harvard Medical School · Location: Brookline · 500 ...

   • Connections: 500+
   • Followers: 2K

   • Works For: American Cancer Society
   • Location: Atlanta< GA

6. pf-media.co.uk › news › avacta-appoints-dr-markAvacta appoints Dr Mark Goldberg as Non-Executive Director

   pf-media.co.uk › news › avacta-appoints-dr-mark

   • Cached

   Aug 20, 2021 · Avacta Group, the clinical stage oncology drug company has announced the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate effect. Dr. Mark Goldberg is a medical oncologist and haematologist on the faculty of Brigham & Women’s Hospital and Harvard Medical School, a veteran biotech executive, and long-time ...

   • Author: Emma Cooper

7. www.yorkshirepost.co.uk › business › avactaAvacta announces appointment of new non-executive director

   www.yorkshirepost.co.uk › business › avacta

   • Cached

   Aug 18, 2021 · Drug devloper Avacta has announced the appointment of Dr Mark Goldberg as a non-executive director. Dr. Goldberg is a medical oncologist and haematologist on the faculty of Brigham &...

8. www.pharmavoice.com › news › pv100-pharma-industryThe 2022 PharmaVoice 100 | PharmaVoice

   www.pharmavoice.com › news › pv100-pharma-industry

   • Cached

   Sep 6, 2022 · Dr. Mark Goldberg has played a significant role in shaping the clinical trial ecosystem over his more than 30-year career — and he’s not done yet. As the CEO and chairman of the recently rebranded Allucent, he has created a global CRO focused on helping small to midsize biopharma companies bring novel treatments to market.